Flower One Holdings Inc.

OTC: FLOOF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#410 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

——

FH —DQ —GM —SS 32

v0.1 · 5/100 weight · pillars only

↑ 3-yr revenue growth, revenue growth (YoY) · ↓ return on equity, Piotroski F

Methodology →

Revenue TTM

$43.0M

Rev growth YoY (TTM)

-20.0%

Net income (FY)

-$24.4M

Employees

Market cap

$4.7k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$57.9M$57.9M2021

Net income-$24.4M-$24.4M2021

Operating income-$29.0M-$29.0M2021

Total assets$117.8M$117.8M2021

Liabilities$117.0M$117.0M2021

Equity$856.7k$856.7k2021

Revenue trend

FY2016 – FY2021 · USD

FY16

FY17

$131.0k

FY18

$9.5M

FY19

$34.2M

FY20

$57.9M

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Flower One Holdings Inc. booked $57.9M in FY2021 revenue, growing 69% year over year — faster than most Healthcare companies we track, at a -42.2% net margin.

Peers · Healthcare

Sentry Petroleum Ltd——Orthometrix, Inc.——Choom Holdings Inc.——Life Stem Genetics Inc.——

Key facts

CEOKellen O'Keefe

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: FLOOF

Employees38

IPO date2018-10-12

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.